Cooper Companies (NASDAQ:COO) Releases FY 2025 Earnings Guidance

Cooper Companies (NASDAQ:COO) issued an update on its FY 2025 earnings guidance on Thursday morning. The company provided earnings per share (EPS) guidance of 3.920-4.020 for the period, compared to the consensus estimate of 4.050. The company issued revenue guidance of $4.1 billion-$4.2 billion, compared to the consensus revenue estimate of $4.2 billion. Cooper Companies also updated its FY25 guidance to $3.92-$4.02 EPS.

Wall Street Analyst Weigh In

A number of analysts have commented on the company. StockNews.com upgraded Cooper Companies from a “hold” rating to a “buy” rating in a research report on Tuesday. Robert W. Baird boosted their price target on Cooper Companies from $118.00 to $125.00 and gave the stock an “outperform” rating in a report on Thursday, August 29th. Stifel Nicolaus reiterated a “buy” rating and set a $115.00 price objective (up previously from $110.00) on shares of Cooper Companies in a research report on Thursday, August 29th. Piper Sandler raised their target price on shares of Cooper Companies from $115.00 to $120.00 and gave the company an “overweight” rating in a research note on Thursday, August 29th. Finally, Needham & Company LLC restated a “hold” rating on shares of Cooper Companies in a research report on Wednesday, November 27th. Three investment analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. According to data from MarketBeat, the company has an average rating of “Moderate Buy” and an average target price of $117.00.

Cooper Companies Trading Down 1.7 %

Cooper Companies stock traded down $1.75 during midday trading on Thursday, reaching $103.23. The stock had a trading volume of 1,849,027 shares, compared to its average volume of 1,143,024. Cooper Companies has a 52-week low of $82.69 and a 52-week high of $112.38. The company has a fifty day moving average of $104.84 and a 200 day moving average of $98.74. The firm has a market cap of $20.56 billion, a price-to-earnings ratio of 57.81, a price-to-earnings-growth ratio of 2.24 and a beta of 0.97. The company has a quick ratio of 1.18, a current ratio of 1.99 and a debt-to-equity ratio of 0.33.

Cooper Companies (NASDAQ:COO) last issued its quarterly earnings results on Thursday, December 5th. The medical device company reported $1.04 earnings per share for the quarter, topping the consensus estimate of $1.00 by $0.04. Cooper Companies had a return on equity of 9.08% and a net margin of 9.45%. The firm had revenue of $1.02 billion for the quarter, compared to the consensus estimate of $1.03 billion. During the same period in the prior year, the business posted $0.87 earnings per share. The company’s revenue for the quarter was up 9.8% on a year-over-year basis. On average, analysts anticipate that Cooper Companies will post 3.65 earnings per share for the current fiscal year.

Insider Activity

In other news, CEO Albert G. White III sold 114,992 shares of the business’s stock in a transaction dated Thursday, September 19th. The shares were sold at an average price of $110.53, for a total transaction of $12,710,065.76. Following the completion of the sale, the chief executive officer now owns 165,273 shares of the company’s stock, valued at $18,267,624.69. The trade was a 41.03 % decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, CAO Agostino Ricupati sold 1,601 shares of the firm’s stock in a transaction dated Tuesday, September 10th. The shares were sold at an average price of $108.03, for a total transaction of $172,956.03. Following the completion of the transaction, the chief accounting officer now directly owns 4,818 shares in the company, valued at $520,488.54. This represents a 24.94 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders own 2.00% of the company’s stock.

About Cooper Companies

The Cooper Companies, Inc, together with its subsidiaries, develops, manufactures, and markets contact lens wearers. The company operates in two segments, CooperVision and CooperSurgical. The CooperVision segment provides spherical lense, including lenses that correct near and farsightedness; and toric and multifocal lenses comprising lenses correcting vision challenges, such as astigmatism, presbyopia, and myopia in the Americas, Europe, Middle East, Africa, and Asia Pacific.